Clomipramine Hydrochloride

盐酸氯米帕明

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameClomipramine Hydrochloride
Drug Alias NameClomipramina Hydrochloride氮丙咪嗪Comipraminum Hydrochloride氯咪唑Chlorimipramine Hydrochloride +[9
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin reuptake inhibitorsNorepinephrine reuptake inhibitors
TargetsNorepinephrine transporterSerotonin transporter
Therapy Area/IndicationsPanic DisorderObsessive-Compulsive DisorderDepression +[4
Global Approved IndicationsPanic DisorderObsessive-Compulsive DisorderDepression
Approved Indications in ChinaPanic DisorderObsessive-Compulsive DisorderDepression
Original Approved Country/TerritoryUnited States
Original Approved Date1989/12/29
Country/TerritoryUnited StatesSouth KoreaMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMallinckrodt
China Registration ClassN/A

Develop Information

Inactive CompaniesSandozSymyoo Inc
Active IndicationsPanic DisorderObsessive-Compulsive DisorderDepression
Inactive IndicationsPremature Ejaculation

Other Information

ATC CodeN06AA04